Haematological cancers in pregnancy

Area of Science:

• Hematology
• Oncology
• Obstetrics & Gynecology

Background:

• Hematological cancers during pregnancy are rare but high-risk for mother and fetus.
• Hodgkin's lymphoma, non-Hodgkin's lymphoma, and acute leukemia are the most common types.
• Diagnosis is complicated by overlapping pregnancy and cancer symptoms and imaging limitations.

Purpose of the Study:

• To provide updated management guidance for hematological cancers in pregnancy.
• To focus on chemotherapy and biological agent therapies.
• To address the complexities of diagnosis and treatment in this population.

Main Methods:

• Review of existing literature and retrospective data.
• Focus on safety and effectiveness of chemotherapy and biological agents.
• Guidance development based on current knowledge and clinical considerations.

Main Results:

• Maternal health preservation is the primary treatment goal.
• Pregnancy termination may be advisable in early stages for adequate therapy.
• Treatment is often feasible in later gestational stages.
• Increased risk of hypercoagulability necessitates thromboprophylaxis.

Conclusions:

• Management of hematological cancers in pregnancy requires a multidisciplinary approach.
• Further collaborative research, including prospective studies, is essential.
• Understanding disease mechanisms and epidemiological data is crucial for improved outcomes.